Leishmaniasis - Authors' reply

Affiliations

¹ Department of Pathogen Molecular Biology and Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK; Médecins Sans Frontières, Delhi, India.
² Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
³ Department of Public Health, Institute of Tropical Medicine, Antwerp 2000, Belgium. Electronic address: mboelaert@itg.be.

Comment

Sakib Burza et al. Lancet. 2019.

. 2019 Mar 2;393(10174):872-873.

doi: 10.1016/S0140-6736(18)33057-5.

¹ Department of Pathogen Molecular Biology and Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK; Médecins Sans Frontières, Delhi, India.
² Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
³ Department of Public Health, Institute of Tropical Medicine, Antwerp 2000, Belgium. Electronic address: mboelaert@itg.be.

No abstract available

Comment on

Leishmaniasis.
Saurabh S. Saurabh S. Lancet. 2019 Mar 2;393(10174):871. doi: 10.1016/S0140-6736(18)33046-0. Lancet. 2019. PMID: 30837138 No abstract available.
Leishmaniasis.
Depaquit J, Gay F, Kaltenbach ML. Depaquit J, et al. Lancet. 2019 Mar 2;393(10174):871-872. doi: 10.1016/S0140-6736(18)33077-0. Lancet. 2019. PMID: 30837139 No abstract available.
Leishmaniasis.
Abdoli A. Abdoli A. Lancet. 2019 Mar 2;393(10174):872. doi: 10.1016/S0140-6736(18)33044-7. Lancet. 2019. PMID: 30837141 No abstract available.